Approach to the Patient With Prolactinoma.
Auriemma RS, Pirchio R, Pivonello C, Garifalos F, Colao A, Pivonello R.
J Clin Endocrinol Metab. 2023 Aug 18;108(9):2400-2423. doi: 10.1210/clinem/dgad174.
Treatment of Prolactinoma.
Inder WJ, Jang C.
Medicina (Kaunas). 2022 Aug 13;58(8):1095. doi: 10.3390/medicina58081095.
Prolactinoma: Medical and Surgical Considerations.
Haider SA, Levy S, Rock JP, Craig JR.
Otolaryngol Clin North Am. 2022 Apr;55(2):305-314. doi: 10.1016/j.otc.2021.12.005. Epub 2022 Mar 4.
[Prolactinoma].
Glezer A, Bronstein MD.
Arq Bras Endocrinol Metabol. 2014 Mar;58(2):118-23. doi: 10.1590/0004-2730000002961.
Prolactinoma in pregnancy.
Molitch ME.
Best Pract Res Clin Endocrinol Metab. 2011 Dec;25(6):885-96. doi: 10.1016/j.beem.2011.05.011.
Diagnosis and Management of Pituitary Adenomas: A Review.
Tritos NA, Miller KK.
JAMA. 2023 Apr 25;329(16):1386-1398. doi: 10.1001/jama.2023.5444.
Hyperprolactinemia and prolactinoma.
Romijn JA.
Handb Clin Neurol. 2014;124:185-95. doi: 10.1016/B978-0-444-59602-4.00013-7.
Prolactinoma extension as a contributing factor in dopamine agonist-induced CSF rhinorrhea: a systematic review of the literature.
Milton CK, Lee BJ, Voronovich ZA, Conner AK, McKinney KA, El Rassi ET, Lim J, Glenn CA.
Br J Neurosurg. 2023 Oct;37(5):976-981. doi: 10.1080/02688697.2021.1903389. Epub 2021 Mar 30.
Prolactinomas.
Wildemberg LE, Fialho C, Gadelha MR.
Presse Med. 2021 Dec;50(4):104080. doi: 10.1016/j.lpm.2021.104080. Epub 2021 Oct 21.
Invasive Giant Prolactinoma.
Alkhaibary A, Alharbi A, Khairy S.
World Neurosurg. 2024 Jan;181:21-22. doi: 10.1016/j.wneu.2023.10.025. Epub 2023 Oct 11.
